Lymphokine-dependent proliferation of T-lymphoid cells: Regulated responsiveness and role in vivo

Critical Reviews in Immunology

Volumn 21, Issue 6, 2001, Pages 487-522

  Boothby, Mark ^a   Mora, Ana L ^a   Stephenson, Linda M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Common gamma chain; Hematopoietin receptors; Protein tyrosine kinases; Stat transcription factors

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; ERYTHROPOIETIN; HERMES ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; JANUS KINASE; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN TYROSINE KINASE; RECEPTOR; STAT PROTEIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; HEMOPOIETIC GROWTH FACTOR; LIGAND;

APOPTOSIS; HUMAN; LYMPHOCYTE PROLIFERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; CELL DIVISION; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE;

ANIMAL; CELL DIVISION; HEMATOPOIETIC CELL GROWTH FACTORS; HUMAN; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-7; LIGANDS; LYMPHOCYTES; LYMPHOKINES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-4; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; ANIMALS; HUMANS;

EID: 0035545163     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (267)

1. Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media
2. The interleukin 2 receptor
3. The multisubunit interlukin-2 receptor
4. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses
5. Differential requirements for survival and profileration of CD8 naïve or memory T cells
6. + cytotoxic T lymphocytes
7. Class II-independent generation of CD4 memory T cells from effectors
8. Persistence of memory CD8 T cells in MCH class I-deficient mice
9. Tetracycline-controllable selection of CD4(+) T cells; half-life and survival signals in the absence of major histocompatibility complex class II molecules
10. How αβ cells deal with induced TCRα ablation
11. How much TCR does a T cell need?
12. Preferential localization of effector memory cells in nonlymphoid tissue
13. Visualizing the generation of memory CD4 T cells in the whole body
14. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery
15. + T cells in lymphopenic hosts
16. Memory T cell development in the absence of specific antigen priming
17. Functional differentiation of T cells in the intestine of T cell receptor transgenic mice
18. T cell memory
19. Turnover of naïve- and memory-phenotype T cells
20. Induction of bystander T cell proliferation by viruses and type I interferon in vivo
21. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15
22. + T cells upon NKT or T cell activation
23. CD4+ cell survival is not directly linked to self-MHC-induced TCR signaling
24. + T cell turnover in vivo by IL-12, IL-18, and IFN-gamma
25. Counting antigen-specific CD8 T cells, a reevaluation of bystander activation during viral infection
26. + T cell survival but not for antigen proliferation
27. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain
28. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
29. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells
30. Stat5 interaction with the T cell receptor complex and stimulation of T cell proliferation
31. Peripheral expression of Jak3 is required to maintain T lymphocyte function
32. + T cell differentiation: Initial antigen encounter triggers a developmental program in naïve cells
33. Cytokine-independent Jak3 activation upon T cell receptor (TCR) stimulation through direct association of Jak3 and the TCR complex
34. Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling
35. Sharing of the interleukin (IL)-2 receptor γ chain between receptors for IL-2 and IL-4
36. Interleukin-2 receptor γ chain: A functional component of the interleukin-4 receptor
37. Functional participation of the IL-2 receptor γ chain in IL-7 receptor complexes
38. Interleukin-2 receptor γ chain; a functional component of the interleukin-7 receptor
39. Sharing of the IL-2 receptor γ chain with the functional IL-9 receptor complex
40. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15
41. Cytokine receptors and signal transduction
42. Signaling through the hematopoietic hernatopoietic cytokine receptors
43. Cytokine signaling through nonreceptor protein tyrosine kinases
44. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment
45. Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor
46. Expression of murine IL-2 receptor β-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor α-chain transgenic mice
47. + T cells of human IL-2 receptor β-chain transgenic mice
48. Differences in the interleukin-2 (IL-2) receptor system in human and mouse: α chain is required for formation of the functional mouse IL-2 receptor
49. Antigen-independent activation of memory cytotoxic T cells by interleukin 2
50. IL-4 induces IL-2 receptor p75 β-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes
51. +CD44 high but not other T cells
52. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice
53. Receptor-stimulated death pathway is opened by antigen in mature T cells
54. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
55. Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex
56. + memory T cells by opposing cytokines
57. Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain
58. The IL-15Ralpha chain signals through association with Syk in human B cells
59. Partial T cell signaling: Altered phospho-zeta and lack of ZAP-70 recruitment in APL-induced T cell anergy
60. Altered T cell receptor ligands trigger a subset of early T cell signals
61. CD4 augments the response of a T cell to agoinst but not to antagonist ligands
62. The dynamics of T cell receptor signaling: Complex orchestration and the key roles of tempo and cooperation
63. Signaling from the IL-2 receptor to the nucleus
64. Biology of the interleukin-2 receptor
65. Signaling via the IL-2 and IL-7 receptors from the membrane to the nucleus
66. Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: Implications for XSCID and XCID
67. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits
68. Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor γ chain in IL-2. IL-4, and IL-7 signaling
69. Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signaling
70. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation
71. Signaling via IL-2 and IL-4 in Jak3-deficient serve combined immunodeficiency lymphocytes: Jak3-dependent and independent pathways
72. Involvement of the Jak-3 Janus Kinase in signalling by Interleukins 2 and 4 in lymphoid and myeloid cells
73. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2
74. Interaction of the IL-2 receptor with the srcfamily kinase p56lck: Identification of novel intermolecular association
75. Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: Activation of syk depends on Jak-3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation
76. Association of p561ck with IL-2 receptor β chain is critical for the IL-2-induced activation of p56lck
77. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor
78. Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions
79. Functional dissection of the cytoplasmic subregions of the IL-2 receptor beta chain in primary lymphocyte populations
80. Identification and purification of human Stat proteins activated in response to interleukin-2
81. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways
82. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells
83. Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet?
84. Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation
85. c chain
86. Constitutive activation of Stat3 by the Src and Jak tyrosine kinases participates in growth regulation of human breast carcinoma cells
87. IL-3 signaling and the role of Src kinases, JAKs and Stats: A covert liaison unveiled
88. Activation of STAT proteins and cytokine genes in human Th1 and Th2 cells generated in the absence of IL-12 and IL-4
89. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β
90. Defects in B lymphocytes maturation and T lymphocyte activation in mice lacking Jak3
91. Defective lymphoid development in mice lacking Jak3
92. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death
93. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2 and bcl-x genes through the trans-activation domain of Stat5
94. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling
95. Three distinct IL2 signaling pathways mediated by bcl-2, c-myc, and Ick cooperate in hematopoietic cell proliferation
96. Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells
97. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes
98. Interleukin 2 exppression by a subpopulation of primary T cells is linked to enhanced memory/effector function
99. In vivo priming of CD4 T cells that produce intereleukin (IL)-2 but not IL-4 or interferon (IFN)-γ, and can subsequently differentiate into IL-4- or IFN-γ-secreting cells
100. Physical and functional interactions between Stat5 and the tyrosinephosphorylated receptors for erythropoietin and interleukin-3
101. The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis
102. The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation
103. Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc
104. Interleukin-2-induced tyrosine phosphorylation of Shc proteins correlates with factor-dependent T cells proliferation
105. Regulation of PtdIns-3-kinase and the guanine nucleotide binding proteins p21ras during signal transduction by the T cell antigen receptor and the interleukin-2 receptor
106. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4
107. p21ras mediates control of IL-2 gene promoter function in T cell activation
108. T cell activation and the cytoskeleton
109. Phosphoinositide 3-kinases in T lymphocyte activation
110. IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase
111. Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase
112. Function of P13Kγ in thymocyte development, T cell activation, and neutrophil migration
113. New role for Shc in activation of the phosphatidylinositol 3-kinases/Akt pathway
114. The docking molecule Gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common gamma chain-using cytokines
115. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α
116. Xid-like immunodeficiency in mice with disruption of the p85 subunit of phosphoinositide 3-kinase
117. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
118. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase
119. Cellular signalling: Pivoting around PDK-1
120. Phosphorylation and activation of pp70 S6K by PDK1
121. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and actives protein kinase Bα
122. 3-Phosphoinositide-dependent protein kinase 1 (PDK-1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
123. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase
124. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin
125. PI3K: Downstream AKTion blocks apoptosis
126. IL-12 enhances IL-2 function by inducing CD25 expression through a p38 mitogen-activated protein kinase pathway
127. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion
128. CD45 tyrosine phosphatase controls common gamma-chain cytokine-mediated STAT and extracellular signal-related kinase phosphorylation in activated human lymphoblasts: Inhibition of proliferation without induction of apoptosis
129. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
130. NF-κB RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses
131. Mechanisms of NF-κB/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells
132. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells
133. IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells
134. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids
135. Negative regulation of cytokine signaling pathways
136. Suppression of STAT5 function in liver, mammary glands, and T cells in cytokines-inducible SH2-containing protein 1 transgenic mice
137. The multi-faceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host responses to intracellular pathogens
138. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy
139. IL-15 and IL-2; a matter of life and death for T cells in vivo
140. A lymphokine, provisionally designated interleukin T and produced by an human adult T-cell leukemia line, stimulates T cell proliferation and the induction of lymphokine-activated killer cells
141. Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of intereleukin-2 that may induce HIV-1 expression
142. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival
143. Activation of naive and memory T cells by interleukin-15
144. + T cell responsiveness to antigen
145. + T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii
146. + intestinal intraepithelial lymphocytes
147. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
148. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
149. T cell-independent interleukin 15ralpha signals are required for bystander proliferation
150. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response
151. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor
152. Cloning of receptor subunit required for signaling by thymic stromal lymphopoietin
153. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice
154. An essential role for the IL-7 receptor during intrathymic expansion of the positively selected neonatal T cell repertoire
155. Induction of germline transcription in the TCRgamma locus by Stat5: Implications for accessibility control by the IL-7 receptor
156. Recombinant IL-7, pre-B cell growth factor, has costimulatory activity on purified mature T cells
157. Regulation of T cell proliferation by IL-7
158. + T-cells from human cord blood
159. Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells
160. Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation
161. Development of lymphocytes in interleukin 7-transgenic mice
162. IL-7 administration alters the CD4:CD8 ratio, increase T cell numbers, and increases T cell function in the absence of activation
163. Essential requirement for c-kit and common gamma chain in thymocyte development cannot be overruled by enforced expression of Bcl-2
164. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice
165. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/mice
166. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo
167. T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo
168. Survival of naive CD4 T cells: Roles of restricting versus selecting MHC class II and cytokine miheu
169. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: Stat6 is probably not required for the effect of IL-4
170. Characterization of a novel high affinity human IL-7 receptor. Expression on T cells and association with IL-7 driven proliferation
171. Association of the common gamma-chain with the human IL-7 receptor is modulated by T cell activation
172. Inhibition of interleukin 7 receptor signaling by antigen receptor assembly
173. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3′ kinase
174. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation
175. Interleukin 7 receptor functions by recruiting the tyrosine kinase p59fyn through a segment of its cytoplasmic tail
176. Interleukin-7 activates p561ck and p59fyn, two tyrosine kinases associated with the p90 interleukin-7 receptor in primary human T cells
177. Interleukin-7 induces the association of phosphoinositol 3-kinase with the alpha chain of the interleukin-7 receptor
178. Interleukin-7: A cofactor for V(D)J rearrangement of the TCR beta chain gene
179. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor
180. The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopolesis
181. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors
182. Control of T cell development in vivo by subdomains within the IL-7 receptor alpha-chain cytoplasmic tail
183. Interleukin-7 induces T cell proliferation in the absence of Erk/MAP kinase activity
184. T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation
185. Gene transfer of the interleukin (IL)-2 receptor chain into an IL-7-dependent pre-B cell line permits IL-2-driven proliferation: Tyrosine phosphorylation of Shc is induced by IL-2 but not IL-7
186. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases
187. Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7
188. Overexpression of suppressor of cytokine signaling-1 impairs pre-T-cell receptor-induced proliferation but not differentiation of immune thymocytes
189. Antigen-independent activation of naive and memory resting T cells by a cytokine combination
190. Cytokine-induced survival of activated T cells in vitro and in vivo
191. B-cell stimulatory factor 1 activates resting B cells
192. Interleukin 4/B cell stimulatory factor-1: One lymphokine, many functions
193. T-cell and mast cell lines respond to B-cell stimulatory factor 1
194. The IL-4 receptor: Signaling mechanisms and biologic functions
195. Interleukin-4-specific signal transduction events are diven by homotypic interactions of the interleukin-4 receptor α subunit
196. Homodimerization of interleukin-4 recep̄tor α chain can induce intracellular signaling
197. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression
198. JAK1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules
199. The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells
200. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
201. An interleukin-4-induced transcription factor: IL-4 Stat
202. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor α
203. Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae
204. Ligand-induced transphosphorylation between different FGF receptors
205. Signal transduction by receptors with tyrosine kinase activity
206. Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits
207. Genetic evidence for Lyn as a negative regulator of IL-4 signaling
208. + T cells in to the Th2 subset
209. Requirement for p56(lck) tyrosine kinase activation in Th subset differentiation
210. Signal transduction by lymphocyte antigen receptors
211. Impaired Th2 subset development in the absence of CD4
212. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor
213. Identification of an essential region for growth signal transduction in the cytoplasmic domain of the human interleukin-4 receptor
214. Fes mediates the IL-4 activation of insulin receptor substrate-2 and cellular proliferation
215. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth
216. Mutational analysis of a critical signaling domain of the human interleukin 4 receptor
217. Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth
218. Cloning of mouse and human Stat6, proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis
219. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor
220. IL-4 function can be transferred to the IL-2 receptor by tyrosine-containing sequences found in the IL-4 receptor alpha chain
221. IRS-1: Essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells
222. JAK kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes
223. PI 3-kinase and pp70 S6K signaling during insulin, IGF-1, and IL-4 stimulation
224. HMG-I(Y) phosphorylation status as a nuclear target regulated through the I4R motif of the IL-4 receptor
225. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/Akt: Involvement of MEK upstream of Bad phosphorylation
226. Cytokine-induced protein kinase B activation and bad phosphorylation do not correlate with cell survival of hemopoietic cells
227. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway
228. IL-4 dependent induction of BCL-2 and Bc1-x(L) in activated T lymphocytes through a STAT6- and PI 3-kinase-independent pathway
229. Akt phosphorylation of BAD couples survival signals to the cell-intrinisic death machinery
230. The PI 3kinase/Akt signaling pathway delivers an anti-apoptotic signal
231. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
232. FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation
233. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells
234. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression
235. Multiple hemopoietic growth factors stimulate activation of mitogen-activated protein kinase family members
236. ras activation from cell growth
237. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion
238. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells
239. Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression
240. Essential role of Stat6 in IL-4 signaling
241. Lack of IL-4-induced Th2 response and IgE class switching in mice with a disrupted Stat6 gene
242. IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells
243. Hennighausen, and K. Friedrich. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain
244. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation
245. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex
246. c-Cbl is tyrosine-phosphorylated in response to interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway
247. The Cb1 protooncoprotein: A negative regulator of immune receptor signal transduction
248. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cb1 on ZAP-70 in T cells
249. Transient inhibition of interleukin 4 signaling by T cell receptor ligation
250. Impaired interleukin 4 signaling in T helper type 1 cells
251. Repression of IL-4-induced gene expression by IFN-γ requires Statl activation
252. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection
253. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
254. Susceptibility to Leishmania major infection in interleukin-4-deficient mice
255. An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptordeficient mice
256. Characterization of the cytoplasmic domain of interleukin-13 receptor-alpha
257. Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-1 and cell proliferation
258. Multiple Stat complexes interact at the interferon regulatory factor-1 interferon-gamma activation sequence in prolactin-stimulated Nb2 T cells
259. IL-6 rescues resting mouse T cells from apoptosis
260. Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling
261. Role of interleukin 1 in the activation of T lymphocytes
262. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function
263. Cutting edge: The common gamma-chain is an indispensable subunit of the IL-21 receptor complex
264. IL-12 enhances CD8 T cell homeostatic expansion
265. The role of antigen and IL-12 in sustaining Thl memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge
266. CD28 costimulation is required not only to induce IL-12 receptor but also to render Janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells
267. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase